News
Biogen’s 4 nominations in the Pharma category for its Friedreich’s ataxia work included 3 in the “direct-to-patient ads for products or services” category and one in the “disease ...
Biogen’s 4 nominations in the Pharma category for its Friedreich’s ataxia work included 3 in the “direct-to-patient ads for products or services” category and one in the “disease awareness and ...
Apraxia and ataxia both have neurological involvement. Learn about the different causes, symptoms, and treatments in this article.
The acquired business, which was founded in 1992, will operate as Buffalo MRI by Windsong Radiology for now.
Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful improvements in cardiac biomarkers and functional measures LX2006 also selected ...
Duke Health and Raleigh Radiology compete for a new MRI scanner license in Wake County, aiming to meet growing population and patient demands.
The Company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 for the treatment of Friedreich ataxia (FA ...
More information: Lukas Hirsch et al, High-performance Open-source AI for Breast Cancer Detection and Localization in MRI, Radiology: Artificial Intelligence (2025).
Biogen has started a new phase 3 trial that aims to extend the use of its Friedreich's ataxia drug Skyclarys to patients as young as two.
Biogen's early-stage spinal muscular atrophy drug salanersen showed safety, motor improvements and 70% reduction in neurodegeneration markers after one-year dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results